NumFin

Abeona Therapeutics Inc.

Simbol: ABEO

NASDAQ

3.26

USD

Tržna cena danes

  • -1.5375

    Razmerje P/E

  • 0.0026

    Razmerje PEG

  • 89.18M

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Abeona Therapeutics Inc. (ABEO) Finančni izkazi

Download
LetniČetrtletno
LinearnoLog
Na grafu so prikazane privzete številke v dinamiki za Abeona Therapeutics Inc. (ABEO). Prihodki podjetja prikazujejo povprečje 1.417 M, ki je 0.659 % gowth. Povprečni bruto dobiček za celotno obdobje je -0.59 M, ki je 0.579 %. Povprečno razmerje bruto dobička je -1.126 %. Rast čistega dobička za lanskoletno poslovanje podjetja je 0.704 %, kar je enako -1.722 % % v povprečju v celotni zgodovini podjetja.,

LetniČetrtletno
10Y20Y30Y40Y

Bilanca stanja

Če pogledamo fiskalno pot podjetja Abeona Therapeutics Inc., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini -0.003. Na področju kratkoročnih sredstev ABEO znaša 55.737 v valuti poročanja. Velik del teh sredstev, natančneje 52.564, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za 0.008%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 0, če obstajajo, v valuti poročanja. To pomeni razliko v višini 0.000% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 4.402 v valuti poročanja. Ta številka pomeni medletno spremembo v višini -0.292%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 14.826 v valuti poročanja. Letna sprememba tega vidika je -0.446%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 2.444, zaloge na 0, dobro ime pa na 0, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 0.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

183.4552.652.145
95
129.3
85
137.8
69.1
40.1
11.5
0.4
0.4
2.5
7
0.6
2.7
6.9
4.4
0.5
2.3
2.6
9.8
20.1
25.8
0.9
1.5
0.4
4.4
1.9

balance-sheet.row.short-term-investments

153.0337.837.912.1
82.4
0
66.2
0
0
0
0
0
0
0
0
0
0
6.8
3.2
0.1
0.5
1.9
8.3
12.7
17.4
0
0
0
0
0

balance-sheet.row.net-receivables

10.92.40.23
0
0
0.1
0.1
0.1
0.1
0
0.1
0.8
0.3
1
0
0.8
1
0.4
4.5
0.8
1.2
1.3
0.2
0.4
0.1
0
0
0
0

balance-sheet.row.inventory

1.0100.30
0
0
0
0
0
0
0
0
0.2
0.2
0
0
0
0
0
0.2
0.1
0.1
0.5
0
0
0
0
0
0
0.1

balance-sheet.row.other-current-assets

4.520.70.47.4
2.7
3.1
3.8
2.7
0.2
0.3
0
0.1
0.3
0.4
0.1
0
0.1
0.4
0.3
0
1.1
0.9
0.9
0.6
0.1
0.1
0
0.1
0.2
0.1

balance-sheet.row.total-current-assets

199.8855.753.155.4
97.7
132.4
88.9
140.6
69.4
40.6
11.6
0.6
1.7
3.3
8.1
0.7
3.5
8.3
5
5.2
4.3
4.8
12.4
20.9
26.4
1.1
1.5
0.5
4.6
2.1

balance-sheet.row.property-plant-equipment-net

36.48811.121.7
18.4
21.2
9.4
1.4
0.7
0.3
0
0
0
0.1
0
0.1
0.1
0.1
0.2
0.3
1
1
0.7
0.5
0.1
0.1
0.2
0.4
0.3
0

balance-sheet.row.goodwill

0000
32.5
32.5
32.5
32.5
32.5
32.5
0
0
0
0
0
0
0
0
0
0
1.9
0
1.9
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0001.4
1.5
36.2
43
4
8.4
6.6
5
0
0
0.4
0.6
0.8
0.5
0.7
0.9
1.1
2.4
4.9
3.4
2.6
3
3.3
0.4
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0001.4
34
68.6
75.5
36.4
40.9
39.1
5
0
0
0.4
0.6
0.8
0.5
0.7
0.9
1.1
4.3
4.9
5.3
2.6
3
3.3
0.4
0.5
0
0

balance-sheet.row.long-term-investments

0000.9
1
1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

000-0.9
-1
-1.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

0.620.301.1
1.1
1.1
0.6
0.4
0.1
0.1
0
0
0
0.1
0
0.1
0.1
0
0.3
0.6
1.5
1.1
1.1
1.4
1
0.2
0.3
0.1
0
0

balance-sheet.row.total-non-current-assets

37.18.311.124.2
53.5
91
85.5
38.2
41.6
39.5
5
0
0
0.5
0.7
0.9
0.7
0.9
1.4
2.1
6.8
7
7.1
4.6
4.1
3.5
0.9
1
0.3
0

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

236.986464.279.6
151.2
223.4
174.4
178.8
111.1
80.1
16.6
0.6
1.7
3.8
8.8
1.6
4.3
9.1
6.4
7.2
11.1
11.8
19.5
25.5
30.5
4.6
2.4
1.4
4.9
2.1

balance-sheet.row.account-payables

10.781.91.84.3
4.7
3.8
6.1
2.4
3.7
0.9
1.9
0.9
2
1.7
3
4.1
2
1.8
1.2
2.9
2.1
1.8
2.5
1.5
1.2
0.7
0.4
0
0
0.1

balance-sheet.row.short-term-debt

6.0311.81.8
2
1.7
10
0
0
0
0.4
0
4.1
2.8
5.5
0
0
0.1
8.8
0.1
8.4
0.3
0.8
0.1
0
0
0.1
0.2
0.2
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

18.354.45.97.6
6.7
6.3
20
0
0
4
4
0
0
0
0
5.5
5.5
5.5
5.5
7.6
5.7
14
14.2
0.5
0
0
0
0.1
0.2
0

Deferred Revenue Non Current

0000
0
0
0
3.1
3.7
4.3
4.9
5.2
2.7
3.3
4.4
4.7
2.2
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

13.7310.64.210.2
34.9
32.9
3.9
0
4
0
0
7.5
0.2
7.4
5.4
4.2
2.8
0.1
0.6
0.7
0.3
0.3
0.3
0.3
0.3
0.1
0
0.5
0.5
0.3

balance-sheet.row.total-non-current-liabilities

133.3635.829.711.6
6.7
6.3
20
3.1
3.7
10.9
8.9
6.4
12.2
9.2
15.3
19.9
7.7
6.4
5.5
7.6
5.7
14
14.2
14
13.5
0
0.1
0.1
0.2
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

23.394.47.69.4
7
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.3
0.2
0

balance-sheet.row.total-liab

172.0349.237.528.2
48.6
45
40.4
8.7
12
12.3
11.8
15.4
18.8
21.4
29.6
28.6
12.7
8.5
16.3
11.4
17.8
17.6
19
16.4
15.5
1
0.6
0.8
0.9
0.4

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
2.470002506530004e+24
2.3900023760000038e+24
1.910002301530004e+24
1.3200021573500012e+22
7.000012748200011e+37
8672
0
0
0
0
0
0.2
0.1
0
0
0
0
0

balance-sheet.row.common-stock

0.910.30.21.5
1
0.8
0.5
0.5
0.4
0.3
0.2
0.3
0.2
0.2
0.2
0.1
0.1
0
0
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0
1.3
1.3
0.3

balance-sheet.row.retained-earnings

-2908-749.5-695.3-655.6
-570.7
-486.5
-410.2
-359.8
-332.5
-310.6
-296.1
-266.4
-268
-255.4
-251.1
-241.8
-134.9
-114.3
-77.7
-66.2
-64.5
-54.2
-47.3
-37.9
-31.9
-26.5
-23.1
-19.7
-15.3
-39

balance-sheet.row.accumulated-other-comprehensive-income-loss

-0.33-0.1-0.10
0
0
-1.6
-0.4
-0.2
0
0
0
-0.9
-0.8
-0.9
-1.3200021573500012e+22
-7.000012748200011e+37
-1
-1
-1
-1.4
-1.3
-1.3
-1.2
-1
-0.9
-0.8
0
0
0

balance-sheet.row.other-total-stockholders-equity

2972.36764.2722705.6
672.3
664.1
545.3
529.8
431.3
378
300.7
251.4
-2.470002506530004e+24
-2.3900023760000038e+24
-1.910002301530004e+24
-27
-8.4
-8556
68.8
62.8
59
49.6
49
47.8
47.7
30.9
25.7
19
18.1
40.4

balance-sheet.row.total-stockholders-equity

64.9514.826.851.4
102.6
178.4
134
170.1
99.1
67.7
4.8
-14.8
-17.1
-17.6
-20.8
-27
-8.4
0.7
-9.9
-4.2
-6.7
-5.8
0.5
9.1
15
3.6
1.8
0.6
4.1
1.7

balance-sheet.row.total-liabilities-and-stockholders-equity

236.986464.279.6
151.2
223.4
174.4
178.8
111.1
80.1
16.6
0.6
1.7
3.8
8.8
1.6
4.3
9.1
6.4
7.2
11.1
11.8
19.5
25.5
30.5
4.6
2.4
1.4
4.9
2.1

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

64.9514.826.851.4
102.6
178.4
134
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

236.98---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

153.0337.837.912.1
82.4
1.1
66.2
0
0
0
0
0
0
0
0
0
0
6.8
3.2
0.1
0.5
1.9
8.3
12.7
17.4
0
0
0
0
0

balance-sheet.row.total-debt

24.395.47.69.4
8.7
8
30
0
0
4
0.4
0
0
2.8
5.5
5.5
5.5
5.6
14.3
7.7
14.1
14.4
15
0.6
13.5
0
0.1
0.3
0.3
0.4

balance-sheet.row.net-debt

-6.04-9.4-6.6-23.6
-3.9
-121.3
11.3
-137.8
-69.1
-36.1
-11.1
-0.4
-0.4
0.3
-1.5
4.9
2.8
5.4
13.1
7.4
12.3
13.6
13.6
-6.9
5.1
-0.8
-1.4
-0.1
-4.1
-1.5

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Abeona Therapeutics Inc. opazno spremenil prosti denarni tok, ki se je spremenil v 0.144. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 37.21, kar kaže na razliko 49.718 v primerjavi s prejšnjim letom. Zanimivo je, da je del delnic podjetja, natančneje 0, odkupilo podjetje samo. To dejanje je povzročilo spremembo v 0.000 v primerjavi s prejšnjim letom. Medtem pa obveznosti podjetja trenutno znašajo 2.04 v valuti poročanja. Družba je pri naložbenju porabila neto denarna sredstva v višini 208000.000 v valuti poročanja. To je premik za -1.009 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 3.2, 0 in 0, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo 0 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane -0.15, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

cash-flows.row.net-income

-54.19-54.2-39.7-84.9
-84.2
-76.3
-56.7
-27.3
-21.9
-14.5
-26.8
4.4
-10.5
-2.5
-7.5
-17.3
-17.2
-21.7
-12.9
-1.7
-10.2
-6.9
-9.4
-6
-5.4
-3.3
-3.4
-4.4
-11.5
0.3

cash-flows.row.depreciation-and-amortization

3.23.24.64.5
5.6
8.7
2.4
0.7
0.8
0.6
0
0
0.4
0.2
0.2
0.3
0.3
2.6
7.1
1.6
1.1
0.9
0.7
0.6
0.5
0.3
0.2
0.2
0.1
0

cash-flows.row.deferred-income-tax

7.92-11.2030.7
32.9
0
-1.3
-1.4
0
0
23.1
-8.3
5.8
-6.3
0.7
0
0
-77
0
-42
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

4.774.83.18.9
8.2
8.2
8.9
5.9
4.8
4.4
1.3
0.4
0.4
1.1
1
0.8
0
77
0
42
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-1.79-1.8-5.9-18.3
1.6
-3.6
7
-2.1
-0.2
-6.1
0.4
3.1
-0.2
-0.7
-2.2
3.7
0.7
1.5
3
3
0
-0.4
-0.7
0.1
0.3
-0.2
1.2
-0.1
0
0.3

cash-flows.row.account-receivables

-0.1-23-3
0
0.1
0
0
0
-0.1
0
0.8
-0.5
685
-982
111
-747
4129
0
622
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-0.5800-16.1
0
-0.1
-1
-2.6
0.2
-0.3
0.7
0.2
0
-0.2
1581.1
-479
570.4
-2476.7
0
0.1
0.1
0.4
-0.5
0
0
0
0
0
0
0

cash-flows.row.account-payables

2.042-10.50.8
-2.2
-1.7
7.7
-1.3
2.8
-1.2
0
-1.2
0.6
53
-601
369
176
-1657
0
490
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-3.15-1.81.60
3.8
-1.8
0.3
1.7
-3.2
-4.5
-0.3
3.3
-0.2
-738.5
-0.3
2.7
1.4
6.2
3
-1109.1
-0.1
-0.7
-0.2
0.1
0.3
-0.2
1.2
-0.1
0
0.3

cash-flows.row.other-non-cash-items

3.0822.2-5.5-6.6
0.9
0.1
0.7
1.3
3.4
5.3
0.3
0.3
0.1
0.6
0.9
10.4
9.7
22.4
0.9
-10.2
0.1
0.1
0.8
0
0.4
0
-1.2
0.8
8.7
0

cash-flows.row.net-cash-provided-by-operating-activities

-37.01000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-0.33-0.3-0.1-4.2
-1.3
-6.5
-19.5
-0.9
-0.5
-0.3
0
0
0
0
0
0
-0.1
0
0
0
-0.2
-0.5
-0.4
-0.4
-0.1
0
-0.1
0
0
0

cash-flows.row.acquisitions-net

-2.340.21.74.2
1.3
0
19.5
0
0
3.7
0
0
0
0
0
0
-65
0
0
0
0
0
-1.3
0
0
-0.1
0
0
0
0

cash-flows.row.purchases-of-investments

-51.64-51.6-78.2-20.2
-170.5
0
-136.1
0
0
0
0
0
0
0
0
0
0
-3.6
-3.1
0
0
0
0
0
-17.4
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

51.975252.690.4
88.1
66.5
70.5
0
0
0
0
0
0
0
0
0
0
0
0
0.4
1.4
6.5
4.4
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

14.1100-4.2
-1.3
0
-19.5
0
0
0
0
0
0
0
0
0
65
0
0.6
9.4
0
0
0
4.1
0
0
0
-0.2
0
0

cash-flows.row.net-cash-used-for-investing-activites

0.210.2-2466.1
-83.7
60
-85.1
-0.9
-0.5
3.4
0
0
0
0
0
0
-0.1
-3.6
-2.5
9.7
1.2
6
2.7
3.7
-17.5
-0.1
-0.1
-0.2
0
0

cash-flows.row.debt-repayment

0000
-1.8
0
0
0
0
-0.4
0
0
-2.8
-2.8
0
0
-0.1
0
0
0
0
0
0
0
0
0
0
-0.2
-0.1
0

cash-flows.row.common-stock-issued

1687.6437.24725.5
0
112.9
0
86.2
42.2
31.4
12.3
0
4654
5.8
13.1
0
2444
0
0
0.6
9.3
0.3
0
0
18.6
2.8
4.6
0
5.5
0

cash-flows.row.common-stock-repurchased

-0.180-26.30
0
0
0
0
0
0
0
0
-4335
2750
0
0
-2425
0
0
0
0
0
0
0
-0.8
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
-11579
0
-319
-271
-168
-82
-19
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

-1650.58-0.122.5-0.6
3.7
1
5.5
6.2
0.3
4.6
11579.4
0
4.7
-2479
168.2
82.2
2.5
7.3
5.3
-4.4
-0.3
-0.7
-0.1
0.6
11.5
-0.1
-0.2
0
1.7
-0.1

cash-flows.row.net-cash-used-provided-by-financing-activities

37.0637.143.224.9
1.9
113.9
5.5
92.4
42.5
35.7
12.7
0
1.9
3.1
13.3
0.2
2.4
7.4
5.3
-3.8
9
-0.4
-0.1
0.6
29.3
2.7
4.4
-0.2
7.1
-0.1

cash-flows.row.effect-of-forex-changes-on-cash

1646.74000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0.260.3-24.325.3
-116.8
111.1
-118.7
68.6
29
28.6
11.1
0
-2.1
-4.6
6.4
-2.1
-4.3
8.7
0.8
-1.4
1
-0.7
-6
-1
7.5
-0.6
1.1
-4
4.4
0.6

cash-flows.row.cash-at-end-of-period

31.4414.814.638.8
13.6
130.4
19.3
137.8
69.1
40.1
11.5
0.4
0.4
2.5
7
0.6
2.7
9.8
1.2
0.3
1.8
0.7
1.4
7.4
8.4
0.9
1.5
0.4
4.4
1.9

cash-flows.row.cash-at-beginning-of-period

31.1914.638.813.6
130.4
19.3
138
69.1
40.1
11.5
0.4
0.4
2.5
7
0.6
2.7
6.9
1.2
0.3
1.8
0.7
1.4
7.4
8.4
0.9
1.5
0.4
4.4
0
1.3

cash-flows.row.operating-cash-flow

-37.01-37-43.5-65.7
-35
-62.8
-39.1
-22.9
-13
-10.4
-1.6
0
-4
-7.6
-6.9
-2.2
-6.6
4.8
-2
-7.3
-9.1
-6.4
-8.6
-5.3
-4.3
-3.2
-3.2
-3.6
-2.7
0.7

cash-flows.row.capital-expenditure

-0.33-0.3-0.1-4.2
-1.3
-6.5
-19.5
-0.9
-0.5
-0.3
0
0
0
0
0
0
-0.1
0
0
0
-0.2
-0.5
-0.4
-0.4
-0.1
0
-0.1
0
0
0

cash-flows.row.free-cash-flow

-37.34-37.3-43.6-69.8
-36.4
-69.3
-58.6
-23.8
-13.5
-10.7
-1.6
0
-4
-7.6
-6.9
-2.3
-6.7
4.8
-2
-7.3
-9.3
-6.8
-9
-5.7
-4.4
-3.3
-3.3
-3.6
-2.7
0.7

Vrstica izkaza poslovnega izida

Prihodki Abeona Therapeutics Inc. so se v primerjavi s prejšnjim obdobjem spremenili za 1.475%. Bruto dobiček podjetja ABEO znaša 0.3. Odhodki iz poslovanja podjetja so 48.5 in so se v primerjavi s prejšnjim letom spremenili za 4.935%. Odhodki za amortizacijo znašajo 3.2, kar je 4.591% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 48.5, ki kaže 4.935% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja -0.065% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so -48.2, ki kažejo 0.065% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je 0.704%. Čisti prihodki v zadnjem letu so znašali -54.19.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

3.53.51.43
10
0
3
0.8
0.9
1
0.9
2
4.4
1.8
0.5
0.4
0.3
0.1
0
0
0.5
1.3
1.1
0.2
0.1
0
0.1
0.4
0.2
2.9

income-statement-row.row.cost-of-revenue

3.23.20.54.5
30.1
8.7
0
0
0
0
0
0.1
0.3
1.2
0.1
0
0
0
0
0
0.2
0.3
0.1
0
0
0
0
0.6
8.3
0

income-statement-row.row.gross-profit

0.30.31-1.5
-20.1
-8.7
3
0.8
0.9
1
0.9
1.9
4.1
0.6
0.3
0.4
0.3
0.1
0
0
0.3
1
1
0.2
0.1
0
0.1
-0.1
-8.1
2.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

31.09---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

-1.59---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

2.942.90.13.3
4.6
7.8
2.4
0.7
0.8
0.6
3.7
4.8
0.4
4.3
0.2
0.3
0.3
4.4
3.1
6.8
4
3.1
2.7
2.4
2.2
1.8
1.7
1.9
2.1
1.4

income-statement-row.row.operating-expenses

48.548.546.260.4
58.5
77.1
61.2
28.7
24.8
19.6
4.1
5.7
8.5
8.5
8.1
10
17.2
7
5.2
9.6
9.4
9.2
9.7
6.6
6.2
3.4
3.5
4.4
3.5
2.6

income-statement-row.row.cost-and-expenses

51.751.746.760.4
58.5
77.1
61.2
28.7
24.8
19.6
4.1
5.8
8.7
9.7
8.2
10
17.2
7
5.2
9.6
9.6
9.5
9.8
6.6
6.2
3.4
3.5
5
11.8
2.6

income-statement-row.row.interest-income

2.122.10.40.1
1.3
1.2
1.5
0.5
2
4
0
0.3
0.2
1.3
2
0
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

0.420.40.73.7
4.1
0.4
0
0
0
0
0.6
0.3
0.6
1
0.6
0.5
0.5
3.5
7.4
2.1
1.4
1.3
1.3
1.2
0.3
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

-1.59---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-5.99-65.64.9
-2.8
0.8
1.5
0.5
2
4
-23.1
8.3
-5.8
5
-1.2
-7.2
-0.3
-11.6
-1.1
-1.9
-1.2
1.3
-0.7
0.3
0.6
0
0
0.1
0.2
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

2.942.90.13.3
4.6
7.8
2.4
0.7
0.8
0.6
3.7
4.8
0.4
4.3
0.2
0.3
0.3
4.4
3.1
6.8
4
3.1
2.7
2.4
2.2
1.8
1.7
1.9
2.1
1.4

income-statement-row.row.total-operating-expenses

-5.99-65.64.9
-2.8
0.8
1.5
0.5
2
4
-23.1
8.3
-5.8
5
-1.2
-7.2
-0.3
-11.6
-1.1
-1.9
-1.2
1.3
-0.7
0.3
0.6
0
0
0.1
0.2
0

income-statement-row.row.interest-expense

0.420.40.73.7
4.1
0.4
0
0
0
0
0.6
0.3
0.6
1
0.6
0.5
0.5
3.5
7.4
2.1
1.4
1.3
1.3
1.2
0.3
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

3.23.20.635.8
38.8
9.9
2.4
0.7
0.8
0.6
0
0
0.4
0.2
0.2
0.3
0.3
2.6
7.1
1.6
1.1
0.9
0.7
0.6
0.5
0.3
0.2
0.2
0.1
0

income-statement-row.row.ebitda-caps

-45---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-48.2-48.2-45.3-89.8
-81.4
-77.1
-58.2
-27.8
-23.9
-18.5
-3.1
-3.8
-4.3
-7.9
-7.8
-9.7
-16.9
-6.9
-5.2
-9.6
-9.1
-8.2
-8.7
-6.3
-6.1
-3.3
-3.4
-4.5
-11.6
0.3

income-statement-row.row.income-before-tax

-54.19-54.2-39.7-84.9
-84.2
-76.3
-56.7
-27.3
-21.9
-14.5
-26.8
4.4
-10.5
-2.5
-9
-16.8
-17.2
-21.9
13.4
-11.6
-10.2
-6.9
-9.4
-6
-5.4
-3.3
0
-4.4
-11.5
0.3

income-statement-row.row.income-tax-expense

00-7.93.7
4.1
0.4
1.5
0.5
2
4
0.6
0.3
0.6
0
-0.2
7.7
0.2
-0.1
-0.2
-4.1
0
0
0
0
0
0
0
-0.1
-0.2
0

income-statement-row.row.net-income

-54.19-54.2-31.8-88.6
-88.3
-76.7
-56.7
-27.3
-21.9
-14.5
-26.8
4.4
-10.5
-2.5
-7.5
-17.3
-17.2
-21.9
-12.9
-1.7
-10.2
-6.9
-9.4
-6
-5.4
-3.3
-3.4
-4.4
-11.5
0.3
Podobne delnice
Morda vas zanima tudi:
MRVI
Maravai LifeSciences Holdings, Inc..
7.7 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.0361 USD
NASDAQ
T5O.DE
CytoTools AG.
0.488 EUR
XETRA
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ
SPHRF
Starpharma Holdings Limited.
0.0991 USD
PNK
ARQT
Arcutis Biotherapeutics, Inc..
8.47 USD
NASDAQ

Pogosto zastavljeno vprašanje

Kaj je Abeona Therapeutics Inc. (ABEO) skupna sredstva?

Abeona Therapeutics Inc. (ABEO) skupna sredstva so 64001999.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so N/A.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.086.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -1.461.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -15.482.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -13.771.

Kaj je Abeona Therapeutics Inc. (ABEO) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -54188000.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 5400000.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 48502000.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 14811000.000.